Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies

Cancer Genetics and Cytogenetics

Volumn 86, Issue 2, 1996, Pages 116-119

  Ganapathi, Ram ^a   Hoeltge, Gerald ^a   Casey, Graham ^a   Grabowski, Dale ^a   Neelon, Rosemary ^a   Ford, Jeanne ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; CELL STRAIN HL 60; CHROMOSOMAL LOCALIZATION; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

EID: 0029976070     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00207-3     Document Type: Article

References (20)

1. Endicott JA, Ling V (1989): The biochemistry of P-glycoprotein mediated multidrug resistance. Ann Rev Biochem 58:137-171.
2. Chin K-V, Pastan I, Gottesman MM (1993): Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157-180.
3. Ford JM, Hait WN (1990): Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155-199.
4. Georges E, Sharom F, Ling V (1990): Multidrug resistance and chemosensitization. Therapeutic implications for cancer chemotherapy. Adv Pharmacol 21:185-220.
5. Trent JM, Callen DF (1991): Chromosomal localization of P-glycoprotein genes in drug sensitive and resistant human cells. In: Roninson IB (ed.): Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Plenum Press, New York, Chapter 8, pp. 169-188.
6. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME (1987): Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47:5141-5148.
7. Fojo AT, Lebo R, Shimizu M, Chin JE, Roninson IB, Merlino GT, Gottesman MM, Pastan I (1986): Localization of multidrug resistance-associated DNA sequences to human chromosome 7. Somat Cell Mol Genet 12:415-420.
8. Sartorelli AC (1985): Malignant cell differentiation as a potential therapeutic approach. Br J Cancer 52:293-302.
9. Cole S, Bhardwaji G, Gerlach J, Mackie J, Grant C, Amquist K, Stewart A, Kurz E, Duncan A, Deeley R (1992): Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258:1650-1654.
10. Center MS (1993): Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drugs. Cytotechnology 12:109-125.
11. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994): Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910.
12. Vig BK (1971): Chromosome aberrations induced in human leukocytes by the antileukemic antibiotic adriamycin. Cancer Res 31:32-38.
13. Yen A, Reece SL, Albright KL (1984): Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J Cell Physiol 118:277-286.
14. Ganapathi R, Grabowski D (1988): Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance. Biochem Pharmacol 37:185-193.
15. Slovak ML, Hoeltge GA, Ganapathi R (1986): Abnormally banded chromosomal regions in doxorubicin-resistant B16-BL6 murine melanoma cells. Cancer Res 46:4171-4177.
16. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Wilman CL, Griffith B, Von Hoff DD, Roninson IB (1990): Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polyrnerase chain reaction. Proc Natl Acad Sci USA 87:7160-7164.
17. Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Sith AJ, Broxterman HJ, Mulder NH, deVries EG, Baas F, Borst P (1993): Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750.
18. Kartner N, Evernden-Porelle D, Bradley G, Ling V (1985): Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820-823.
19. Ganapathi R, Kamath N, Constantinou A, Grabowski D, Ford J, Anderson A (1991): Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: Relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells. Biochem Pharmacol 41:R21-R26.
20. Gervasoni Jr JE, Taub RN, Yu MT, Warburton D, Sabbath M, Gilleran S, Coppock DL, D'Alessandri J, Krishna S, Rosado M, Bake MA, Lutzky J, Cahnda ER, Gerlach JH, Pinkoski MJ, Cole SPC, Hidenburg AA (1992): Homogeneously staining region in anthracycline-resistant HL-60/AR cells not associated with MDR1 amplification. Cancer Res 52:5244-5249.